Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services globally. Its Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, including drug and vaccine discovery and production. The Analytical Instruments segment serves pharmaceutical, biotechnology, academic, government, environmental, and industrial markets with instruments, consumables, software, and services. The Specialty Diagnostics segment provides clinical diagnostics products such as immunodiagnostic reagent kits, blood-test systems for allergy and autoimmune diseases, microbiology offerings, and transplant diagnostics. The Laboratory Products and Biopharma Services segment supplies laboratory products and biopharma services.

Thermo Fisher Scientific Inc. is listed on the New York Stock Exchange (NYSE) under the ticker symbol TMO. Its stock trades in US Dollars (USD), reflecting its primary listing in the United States. The company is headquartered in the United States and operates globally, but its financial reporting and stock trading are denominated in USD.

Thermo Fisher Scientific Inc. operates in the Healthcare sector, specifically within the Diagnostics & Research industry. This classification reflects its focus on providing products and services for scientific research, clinical diagnostics, and biopharma development. The company's offerings support a wide range of applications, from basic biological research to clinical testing and drug manufacturing, making it a key player in the healthcare and life sciences ecosystem.

Thermo Fisher Scientific Inc. is headquartered in the United States and serves global markets. Its products and services are used by pharmaceutical and biotechnology companies, academic and government research institutions, environmental and industrial labs, and clinical laboratories worldwide. The company's global reach is supported by its four business segments, which provide solutions for research, diagnostics, and biopharma services across many countries and regions.

Thermo Fisher Scientific generates revenue through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. The Life Sciences segment sells reagents, instruments, and consumables for research and drug development. Analytical Instruments provides instruments and software for various markets. Specialty Diagnostics offers diagnostic kits and systems for clinical labs, including immunodiagnostics, microbiology, and transplant diagnostics. Laboratory Products and Biopharma Services supplies lab consumables and services to biopharma customers. The company's diverse portfolio allows it to serve customers across the entire research and clinical workflow.